Engineering and Development

Management and Executive

Product Management

Customer Service and Support

Accounting and Finance

Sales

Human Resources

Legal and Compliance

Public Sector and Government

Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Director, Strategic Programs & Portfolio MSAT Advanced Therapies, LCM

Johnson & Johnson is a leader in healthcare innovation, committed to developing treatments and pioneering solutions for complex diseases. The Director, MSAT Strategic Programs and Portfolio Execution will lead global cross-functional teams to implement high-value technical solutions that enhance product life cycles and drive operational excellence.

VP Head of Global Development, Global Public Health

Director, Clinical Development, Interventional Oncology at Johnson & Johnson

Strategic & Innovative Programs, Director

 Director, Strategic Programs - Patient Engagement & Customer Solutions

Director of Nursing Programs and Strategies

Sign up with Google

Sign in with Google